Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,727 followers.

RT @FrontOncology: New research: Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid…

06 Feb 2024

Reply Repost Favourite

New research: Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer: Background Although the incidence of anaplastic thyroid carcinoma (ATC) is low (2.5% of thyroid cancer cases), this… https://t.

06 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.